Liu, Xiaoyu
Tan, Qingqing
Wen, Jiaqi
Wang, Xufei
Yang, Gang
Li, Yuxiao
Lu, Ming
Ye, Wei
Si, Anfeng
Ma, Sujuan
Ding, Tong
Sun, Luan
Liu, Fang
Zhang, Mei
Jiang, Tao
Gao, Wei http://orcid.org/0000-0002-7889-1662
Funding for this research was provided by:
National Natural Science Foundation of China (81972284, 81773260, 82273239)
National Natural Science Foundation Youth Project of Jiangsu (BK20171047)
Article History
Received: 24 December 2022
Accepted: 19 May 2023
First Online: 25 August 2023
Declarations
:
: For clinical samples, the Ethical Committee of Jiangsu Taizhou People’s Hospital approved this study (IRB ID: KY-2022-172-01), and each patient provided written informed consent. For animal tests, all mice received humane care according to the criteria outlined in the Guide for the Care and Use of Laboratory Animals prepared by the National Academy of Sciences and published by the National Institutes of Health. All mice were treated under the protocol approved by the Ethics Committee of the Animal Core Facility of Nanjing Medical University. "Regulation mechanism of pH responsive antibody for anti-tumor activity of antibody conjugate" has been approved by the Institutional Animal Care and Use Committee (IACUC) under the ethical review number "No. IACUC-2107004". The research project, funded by the Natural Science Foundation of China (NSFC) under the grant numbers 81972284/81773260, is conducted in compliance with relevant ethical and legal guidelines.
: Not applicable.
: The authors declare that they have no conflicts of interest with the contents of this article.